These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7938923)

  • 1. Monotherapy is appropriate for nosocomial pneumonia in the intensive care unit.
    Arbo MD; Snydman DR
    Semin Respir Infect; 1993 Dec; 8(4):259-67. PubMed ID: 7938923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit.
    Lynch JP
    Semin Respir Infect; 1993 Dec; 8(4):268-84. PubMed ID: 7938924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
    Kollef MH
    Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
    Akova M
    Int J Clin Pract Suppl; 2002 Mar; (125):19-27; discussion 37-9. PubMed ID: 12014853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to therapy of respiratory infections in the critical care setting.
    Pennington JE
    Semin Respir Infect; 1990 Sep; 5(3):226-32. PubMed ID: 2255806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist-managed aminoglycoside therapy in combination with a beta-lactam agent in the treatment of nosocomial pneumonia in critically ill patients.
    Wade WE; McCall CY
    Pharmacotherapy; 1995; 15(2):216-9. PubMed ID: 7624269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of severe infections: should one always administer an aminoglycoside?].
    Cometta A; Baumgartner JD
    Schweiz Med Wochenschr Suppl; 1996; 76():28S-33S. PubMed ID: 8677416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephalosporin therapeutics for intensive care infections.
    Salacata A; Chow JW
    New Horiz; 1993 May; 1(2):181-6. PubMed ID: 7922401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.
    Chastre J; Luyt CE; Combes A; Trouillet JL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
    Bratzler DW; Ma A; Nsa W
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the treatment of Pseudomonas aeruginosa pneumonia.
    El Solh AA; Alhajhusain A
    J Antimicrob Chemother; 2009 Aug; 64(2):229-38. PubMed ID: 19520717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology and antibiotic therapy in nosocomial pneumonia].
    Fagon JY
    Rev Pneumol Clin; 2001 Apr; 57(2):132-8. PubMed ID: 11353919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
    Beaucaire G
    J Chemother; 1995 Jun; 7 Suppl 2():165-73. PubMed ID: 8622107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia.
    Brito V; Niederman MS
    Curr Opin Infect Dis; 2009 Jun; 22(3):316-25. PubMed ID: 19352176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
    Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.